Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"Histiocytic sarcoma"”.

  1. A novel approach to the clinical diagnosis and treatment of canine histiocytic sarcoma

    This work provides a review of canine histiocytic sarcoma (HS) including background immunology, diagnosis, treatment, and prognosis. Given the poor prognosis of HS compared to other soft tissue sarcomas in dogs, the research performed focuses on diagnosis including immunohistochemistry (IHC), the …

    missouri Repository record for A novel approach to the clinical diagnosis and treatment of canine histiocytic sarcoma (opens in a new tab)

  2. Evaluation of the microenvironment and immune function in histiocytic sarcoma, a tumour of dendritic cells

    Canine histiocytic sarcoma (HS) is a highly aggressive tumour of histiocytic origin and it accounts for up to 50% of malignant tumours in flatcoated retrievers (FCR). Effective treatment has yet to be found, and prognosis is always poor. In recent years, in human and veterinary oncology, there has …

    cambridge Repository record for Evaluation of the microenvironment and immune function in histiocytic sarcoma, a tumour of dendritic cells (opens in a new tab)

  3. Evaluation of the therapeutic potential of Akt inhibition in a translational model of histiocytic sarcoma

    Histiocytic sarcoma (HS) is an exceptionally rare malignant neoplasm derived from dendritic cells and histiocytes, with no available effective treatment options. Akt signaling and proteasome dysfunction have been implicated in the pathogenesis of the disease, both in humans and dogs. Our work aims …

    vt Repository record for Evaluation of the therapeutic potential of Akt inhibition in a translational model of histiocytic sarcoma (opens in a new tab)

  4. Insights into determinants of cancer susceptibility, initiation, and progression:studies on medulloblastoma and Histiocytic Sarcoma in mouse models

    … Chapter three discusses a mouse model of Histiocytic Sarcoma (HS) that was developed to identify genes that can contribute to initiation and cause progression of disease. The genetics of HS are not well understood. Our model could provide important information on molecular targets that can …

    umn Repository record for Insights into determinants of cancer susceptibility, initiation, and progression:studies on medulloblastoma and Histiocytic Sarcoma in mouse models (opens in a new tab)

  5. Optimization and toxocologic effects of cancer immuno-electrogene therapy using a tumor-targeted interleukin-12 gene construct

    … and lymph node metastases; one dog had cubital histiocytic sarcoma with spleen metastases; and one had soft palate fibrosarcoma. Treatment of all six dogs was associated with minimal side effects, was easy to perform, was associated with repair of bone lysis in cured dogs; improved the quality …

    lsu-thes Repository record for Optimization and toxocologic effects of cancer immuno-electrogene therapy using a tumor-targeted interleukin-12 gene construct (opens in a new tab)

  6. Investigations into the role of inflammation in tumorigenesis

    … explore this complicated role with a focus on histiocytic sarcoma (HS) and breast cancer. Chapter 1 opens with a broad overview of inflammation in tumorigenesis while Chapter 2 focuses on a review and discussion of current HS literature. Our investigations into the role of inflammation …

    vt Repository record for Investigations into the role of inflammation in tumorigenesis (opens in a new tab)

  7. Overactive NF-KB signaling as a druggable target and evaluation of parthenolide an NF-KB inhibitor in canine cancer

    … that carry dismal prognoses in both species: histiocytic sarcoma (HS), hemangiosarcoma (HSA), and disseminated mastocytosis (MCT). Lymphoma is one of the most common cancer types affecting dogs and humans, and therefore, novel therapeutic approaches are always needed. For all of these cancer …

    colostate Repository record for Overactive NF-KB signaling as a druggable target and evaluation of parthenolide an NF-KB inhibitor in canine cancer (opens in a new tab)